Clinical Trials Logo

Hunter Syndrome clinical trials

View clinical trials related to Hunter Syndrome.

Filter by:
  • Available  
  • Page 1

NCT ID: NCT05795361 Available - Hunter Syndrome Clinical Trials

Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome

Start date: n/a
Phase:
Study type: Expanded Access

As the HGT-HIT-046 (NCT01506141) and SHP609-302 (NCT02412787) studies will be closed, this post-trial access (PTA) program provides TAK-609 to participants in these studies for whom the benefit:risk ratio of continued treatment with idursulfase-IT remains positive.